"Manufacturing these cutting-edge products inherently requires a workforce with enhanced knowledge and skills." ...

After 13 years of falling enrollment, the Albany College of Pharmacy and Health Sciences is planning to merge with Russell Sage College. The colleges announced the merger plan to their communities ...

In a report released today, Vikram Purohit from Morgan Stanley maintained a Hold rating on SAGE Therapeutics (SAGE – Research Report), with a ...

Trump administration probing extent to which pharmaceutical imports may threaten national security, a likely prelude to ...

Kaskela Law LLC announces that it is investigating Sage Therapeutics, Inc. (NASDAQ: SAGE) (“Sage”) on behalf of the company’s long-term investors.

Sage Therapeutics faces challenges with a 90% value drop but shows promise with Zurzuvae for postpartum depression. Click ...

India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America, could be significantly impacted by the move. Speaking at an event at the National Republican ...

Aspire intends to request "fast track" approval on FDA application for its high-dose aspirin product HUMACAO, PR AND NEW YORK, NY / ACCESS Newswire / April 9, 2025 / Aspire Biopharma Holdings ...

President Trump said Tuesday his administration soon would announce “major” tariffs on pharmaceuticals, adding to the tariffs he has already imposed on most goods entering the United States ...

today announced that management will participate in one-on-one investor meetings at the Piper Sandler Spring Biopharma Symposium on Wednesday, April 16th in Boston. Actio Biosciences is leveraging ...

President Donald Trump said Tuesday that pharmaceutical imports will soon be hit with “major” tariffs as part of his efforts to drive manufacturing back to the U.S. Drug imports evaded the ...

YONGIN, South Korea, April 9, 2025 /PRNewswire/ -- GC Biopharma announced 09. Apr. 2025 that the Korean Ministry of Food and Drug Safety (MFDS) has approved its anthrax vaccine, BARYTHRAX, jointly ...